
Framework Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10
Best for: aggressive $25/week pricing with a named 503B pharmacy partner
Price is where Framework scores best in our breakdown.
Semaglutide
Tirzepatide
Price checked on Framework’s site,
What the monthly price covers
Medication
Included
Provider visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Included
No insurance needed · Vetted by our editors
Framework is a personalized-plan GLP-1 telehealth platform offering compounded semaglutide and tirzepatide with doctor-guided treatment selection. It names its pharmacy partner, The Pharmacy Hub, which operates on the FDA-registered 503B outsourcing pathway rather than the patient-specific 503A compounding most direct-to-consumer competitors use. Pricing starts as low as $25/week (roughly $100/mo) with no membership fees.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Framework
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology

from $108/mo (“starting at” price) · no insurance needed
Framework at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $108/mo (“starting at” price)
- What's included
- Medication · Coaching
- FDA status
- No FDA warning letter on record
How we scored Framework
Each dimension is scored algorithmically from Framework’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.6/10At $108/mo (“starting at” price), Framework runs about 39% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
7.1/10Framework offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
5.9/10Online intake and platform experience; 5 platform features disclosed.
Trust & Safety15%
6.3/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.1/10Framework's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
6.2/10Coaching/dietitian access included.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Framework review
Last checked November 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $108/mo across 2 dose/plan tiers (checked November 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Framework
We walked Framework’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Start an online visit, described as taking less than 3 minutes.
- 2Provide your medical information through the intake portal.
- 3A licensed provider reviews your information and prescribes compounded GLP-1 if appropriate.
- 4If prescribed, your compounded semaglutide or tirzepatide is dispensed.
- Offers compounded semaglutide and tirzepatide.
- Advertises 'GLP-1s for as low as $25/week' and '$0 membership fees' up front, before intake.
- Signup is positioned as fast ('less than 3 minutes').
- Homepage carries a disclaimer that its compounded medications are not FDA-approved and are not substitutes for FDA-approved medications.
- Refund/cancellation, shipping, and lab details are not stated on the homepage.
Framework customer support
- Phone
- (888) 412-0666
GLP-1 medications Framework offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Framework prices per week ('GLP 1s For As Low as $25/Week'). Fifty-two weeks is $1,300 a year, so a calendar month works out to $108.33 rather than $100. It also advertises '$0 membership fees.'
Same per-week rate; Framework quotes one figure for semaglutide and tirzepatide alike.
Ready to get started?
Plans and promotions change often, so check Framework's current pricing and active discounts before you decide.
What we like
- Names its 503B pharmacy partner, The Pharmacy Hub (an FDA-registered outsourcing facility, distinct from 503A)
- Publishes the FDA compounded-medication disclaimer
- $25/week pricing (~$100/mo) is among the most aggressive in the directory
- $0 membership fees
- Phone support published, toll-free (888) 412-0666
- Personalized plans rather than a one-size-fits-all marketplace
Watch-outs
- LegitScript ID / certification not shown on the homepage
- States-served list not disclosed
- Medical director / clinical leadership not disclosed
- Corporate legal entity not disclosed (no footer copyright)
- Governing law / arbitration venue not stated
- Refund / cancellation policy not detailed
- Per-dose pricing tiers not shown (only the 'as low as $25/week' starting tier)
Framework: the rare telehealth brand that names its 503B pharmacy
Most direct-to-consumer GLP-1 startups keep their pharmacy a secret and lean on a low headline number to win you over. Framework does the cheap-number thing too. It advertises compounded semaglutide and tirzepatide for as little as a quarter of a hundred dollars a week, which works out to roughly $108.33 a month (“starting at” price) with no membership fee on top. What is unusual is that it tells you who makes the medicine: The Pharmacy Hub, an FDA-registered 503B outsourcing facility. Few rivals disclose that much.
Why the 503B detail matters to you
Compounded GLP-1s can be made two ways. The common one for telehealth is 503A: a pharmacy mixing a batch for a specific named patient, with lighter federal oversight. The other is 503B, an outsourcing facility that registers with the FDA, gets inspected like a manufacturer, and follows stricter quality-control rules. Framework says its partner, The Pharmacy Hub, runs on the 503B pathway. In plain terms: the place making your shots is held to a higher manufacturing standard than the patient-by-patient model most competitors use. Framework is one of the only providers on this site that both names the pharmacy and points to that registration. For a product where you're injecting yourself weekly, knowing the source is not a small thing.
How the pricing works
Framework's pitch is one clear price with zero membership fees, and the medication is included in what you pay. The advertised rate is a starting tier, as the "as low as" wording signals. The site shows the entry price of about $108.33 a month (“starting at” price) but does not publish a full per-dose ladder, so what you pay as your dose climbs over the months isn't spelled out up front. That's normal for compounded programs (higher doses usually cost more), but it means the headline isn't a guaranteed flat rate. Even so, the entry point is aggressive: it sits well below our category median of $179 a month, and because there's no separate membership charge, you're not stacking a recurring fee on top of the drug.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
- What's included: the compounded medication itself, plus dietitian support and clinician check-ins
- Membership fee: none, which saves money versus programs that bill a monthly platform charge on top of the drug
- Dose pricing: only the starting tier is published, so confirm your price at the dose you'll be taking before you commit
The medications and how you get them
You're choosing between compounded semaglutide (the molecule in Ozempic and Wegovy) and compounded tirzepatide (the one in Mounjaro and Zepbound). These are compounded versions, not brand-name pens, and Framework is upfront about what that means. The site publishes the full FDA disclaimer in plain sight: these formulations aren't FDA-approved and haven't been through clinical trials for safety, efficacy, or equivalence to the approved drugs. Framework says U.S.-licensed clinicians guide the selection between the two drugs rather than letting you just pick off a menu, which fits its "personalized plan" positioning.
What Framework doesn't tell you
Framework also leaves several blanks. The homepage doesn't show a LegitScript certification, which is the badge serious telehealth pharmacies usually display. It doesn't list which states it serves, so you can't confirm coverage where you live without contacting them. There's no named medical director or clinical leadership, no corporate legal entity in the footer (no LLC or Inc. to identify who you're doing business with), and no published refund, cancellation, or arbitration terms. None of these are deal-breakers on their own, but together they lower Framework's score. The pharmacy disclosure is strong; the corporate and regulatory transparency around it is thin. Shoppers who want a practice they can locate can compare Alegro Health, a McKinney, Texas clinic with a published address and hours, but it offers only semaglutide and doesn't list the states it serves.
Who should choose Framework, and who shouldn't
Framework is a good fit if your priority is a low monthly cost from a provider that's willing to name its pharmacy and point to a higher-grade 503B manufacturing pathway. If you've been comparing programs and you care more about where the medicine comes from than about brand-name pens, this is one of the cheaper credible options to look at.
Skip it if you need certainty before you sign up. If you want to confirm your state is covered, see a published refund policy, know the name of the medical director overseeing your care, or get an exact price for the higher dose you'll eventually reach, Framework doesn't put those answers on the page. When a set dose price and written refund terms are your priorities, Factor Health MD charges one flat rate at every dose and publishes its refund agreement, but its weight-loss plans carry a three-month commitment. Anyone who wants brand-name Wegovy or Zepbound should also look elsewhere, since this is a compounded-only program.
Getting your questions answered
Framework publishes a toll-free phone line, (888) 412-0666, plus an email at support@yourframework.com. Before you pay, use the phone number to confirm three things the site leaves out: whether they ship to your state, what the price becomes at higher doses, and what happens if you want to cancel. A provider that answers those clearly over the phone earns a lot more trust than the homepage alone gives.
Bottom line
Framework does well on two things that are hard to fake: a named, FDA-registered 503B pharmacy partner and a visible FDA disclaimer, paired with a low $108.33 (“starting at” price)-a-month starting price and no membership fee. Both strengths can be checked. The weakness is everything around them: no disclosed states, no LegitScript, no named clinical leadership, no corporate entity, no posted refund terms. If transparency about the pharmacy is what you weight most, Framework is one of the better-value picks on this site. If you need the full paperwork before trusting a telehealth brand, call them first and get the gaps filled in before you commit. You can see how we weigh these signals in our scoring methodology.
The Bottom Line
Price is where Framework scores best in our breakdown.
Ready to start with Framework?
From $108/mo (“starting at” price). See current pricing and start your free consultation.
Framework might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Framework vs…
Framework scores6.6/10
Side-by-side pricing, medications and scores. Pick a matchup.
Framework vs Amazon One Medical
Amazon One Medical scores 8.5/10

Framework vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Framework review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Framework's current pricing
Plans from $108/mo (“starting at” price). Start your free consultation to check eligibility and today's price.